English
Home > Products > CAS NO 79200-56-9

China CAS NO 79200-56-9 Factory

We know that we only thrive if we could guarantee our combined price tag competiveness and quality advantageous at the same time for CAS NO 79200-56-9,79200-56-9,Abacavir intermediate,Abacavir advance intermediate,((1R,4S)-2-Azabicyclo[2.2.1]hept-5-en-3-one, Our ultimate goal is to rank as a top brand and to lead as a pioneer in our field. We are sure our successful experience in tool production will win customer's trust, Wish to co-operate and co-create a better future with you!
CAS NO 79200-56-9, Welcome any of your inquiries and concerns for our products. We look forward to establishing a long-term business relationship with you in the near future. Contact us today. We are the first business partner to suit your needs!

Related Products

Hot Products

  • Aminophylline

    Aminophylline

    Product Name:Aminophylline
    Molecular Weight:420.43
    CAS Registry Number:317-34-0
  • 3-Nitrophthalic anhydride

    3-Nitrophthalic anhydride

    Product Name:3-Nitrophthalic anhydride
    Molecular Formula:C8H3NO5
    Molecular Weight:193.11
    CAS Registry Number:641-70-3
  • 2-Octyl cyanoacetate

    2-Octyl cyanoacetate

    Product Name:2-Octyl cyanoacetate
    Molecular Formula:C11H19NO2
    Molecular Weight:197.27
    CAS Registry Number:52688-08-1
  • 4-Phenoxyphenyl boronic acid

    4-Phenoxyphenyl boronic acid

    Product Name:4-Phenoxyphenyl boronic acid
    Molecular Formula:C12H11BO3
    Molecular Weight:214.02
    CAS Registry Number:51067-38-0
  • Anthranilic acid

    Anthranilic acid

    Product Name:Anthranilic acid
    Molecular Formula:C7H7NO2
    Molecular Weight:137.14
    CAS Registry Number:118-92-3
  • Tert-Butyl [(1R,2S,5S)-2-Amino-5-[(Dimethylamino)Carbonyl]Cyclohexyl]Carbamate Oxalate

    Tert-Butyl [(1R,2S,5S)-2-Amino-5-[(Dimethylamino)Carbonyl]Cyclohexyl]Carbamate Oxalate

    Product ​Name:Tert-Butyl [(1R,2S,5S)-2-Amino-5-[(Dimethylamino)Carbonyl]Cyclohexyl]Carbamate Oxalate
    Molecular Formula:C14H27N3O3.C2H2O4
    Molecular Weight:375.42
    CAS NO:1210348-34-7
    Usage:Edoxaban Tosylate Monohydrate
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept